---
company: NLIGHT, INC.
ticker: LASR
form: 8-K
filed: 2026-05-07
accession: 0001124796-26-000025
source: https://www.sec.gov/Archives/edgar/data/1124796/000112479626000025/
---

# Nlight (LASR) earnings release, May 7, 2026

Nlight, Inc. (LASR) · Form 8-K, Item 2.02 · Filed 2026-05-07 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1124796/000112479626000025/)

nLIGHT, Inc. Announces First Quarter 2026 Results

Revenues of $80.2 million increased 55% year-over-year

Record A&D product revenues of $33.1 million increased 98% year-over-year

CAMAS,

Wash.,

May 7, 2026

- nLIGHT, Inc. (Nasdaq: LASR), a leading provider of high-power lasers for mission critical directed energy, optical sensing, and advanced manufacturing applications, today reported record financial results for the first quarter of 2026.

“Our first quarter results represent another strong quarter of execution for nLIGHT with total revenue, gross margin, and Adjusted EBITDA all above our expectations. Our results were again driven by strength in our A&D markets with record defense product revenue nearly doubling year-over-year,” commented Scott Keeney, nLIGHT’s President and Chief Executive Officer. “Looking ahead, we remain encouraged by the pipeline of directed energy opportunities, including follow‑on production content, upgrades to existing platforms, and new prototype programs that should position us for continued growth over the next several years.”

First Quarter 2026 Financial Highlights

*Not meaningful

Revenues of $80.2 million for the first quarter of 2026 were up 55.2% compared to $51.7 million for the first quarter of 2025. Gross margin was 33.1% for the first quarter of 2026 compared to 26.7% for the first quarter of 2025. GAAP net income for the first quarter of 2026 was $0.6 million, or $0.01 per diluted share, compared to GAAP net loss of $8.1 million, or $0.16 per diluted share, for the first quarter of 2025. Non-GAAP net income for the first quarter of 2026 was $11.8 million, or $0.22 per diluted share, compared to non-GAAP net loss of $1.9 million, or $0.04 per diluted share, for the first quarter of 2025. Reconciliations of the non-GAAP metrics presented here to the most directly comparable GAAP metric have been provided in the tables included at the end of this release.

Outlook

For the second quarter of 2026, nLIGHT expects revenues to be in the range of $75 million to $81 million. The midpoint of $78 million includes Products revenue of approximately $58 million and Advanced Development revenue of approximately $20 million. nLIGHT expects overall gross margin to be in the range of 29% to 33%, with Products gross margin in the range of 37% to 41% and Advanced Development gross margin of approximately 8%. nLIGHT expects Adjusted EBITDA to be in the range of $8 million to $12 million.

We have not reconciled our outlook for Adjusted EBITDA because unrealized and realized foreign exchange gains and losses cannot be reasonably calculated or predicted nor can the probable significance be determined at this time. Accordingly, a reconciliation is not available without unreasonable effort.

Investor Webcast at 2:00 p.m. Pacific Time, Thursday, May 7, 2026

A webcast to discuss the first quarter results will be held on Thursday, May 7, 2026, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). The audio webcast will be available on the investor relations section of the company's web site at http://investors.nlight.net. A replay of the webcast will be available shortly after the conclusion of the call.

The webcast can also be accessed directly at https://events.q4inc.com/attendee/724898168.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release contains non-GAAP financial results, including non-GAAP gross margin, Adjusted EBITDA, non-GAAP net income (loss) and non-GAAP net income (loss) per share, basic and diluted. We use Adjusted EBITDA to help us evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. In addition to our results determined in accordance with GAAP, we believe Adjusted EBITDA is a meaningful measure of performance as it is commonly utilized by us and the investment community to analyze operating performance in our industry. Similarly, we believe that providing non-GAAP gross margin, non-GAAP net income (loss) and non-GAAP net income (loss) per share, basic and diluted, is useful to our investors as they present an informative supplemental view of our results from period to period by removing the effect of stock-based compensation expense and other non-recurring items. However, the non-GAAP metrics presented herein are specific to us and may not be comparable to similar metrics disclosed by other companies because of differing methods used by other companies in calculating them.

We define Adjusted EBITDA as net income (loss) adjusted for income tax expense (benefit), other non-operating income or expense, interest income or expense, depreciation and amortization, stock-based compensation, acquisition and integration-related costs, and other non-recurring items as determined by management, as applicable. We define non-GAAP gross margin as GAAP gross margin adjusted for stock-based compensation and other non-recurring items as determined by management, as applicable. We define non-GAAP net income (loss) as GAAP net income (loss) adjusted for stock-based compensation, amortization of purchased intangibles, acquisition and integration-related costs, and other non-recurring items as determined by management, as applicable. We define non-GAAP net income (loss) per share, basic and diluted, as non-GAAP net income (loss) divided by the weighted-average number of shares outstanding during the respective period plus the dilutive effect of any common stock equivalents during the period in the case of non-GAAP net income (loss) per share, diluted.

Tables presenting the reconciliation of net loss to Adjusted EBITDA, as well as the reconciliation of GAAP to non-GAAP gross margin, GAAP to non-GAAP net income (loss) and GAAP to non-GAAP net income (loss) per share, basic and diluted, are included at the end of this press release.

Safe Harbor Statement... (truncated)ection 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Words such as “outlook,” “guidance,” “expects,” “intends,” “projects,” “plans,” “believes,” “estimates,” “targets,” “anticipates,” and similar expressions may identify these forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements regarding expected revenues, gross margin, and Adjusted EBITDA, and our business strategy and ability to profitably grow our business, as well as any other statement that does not directly relate to any historical or current fact. Forward-looking statements are based on our current expectations and assumptions, which may not prove to be accurate. These statements are not guarantees and are subject to risks, uncertainties and changes in circumstances that are difficult to predict. Many factors could cause actual results to differ materially and adversely from these forward-looking statements, including but not limited to our ability to compete successfully in the markets for our products; changes in the markets we serve or in the global economy; our ability to increase our volumes and decrease our costs to offset potential declines in the average selling prices of our products; rapid technological changes in the markets that we participate in; our ability to develop and maintain products that can achieve market acceptance; our ability to generate sufficient revenues to achieve or maintain profitability in the future; our high levels of fixed costs and inventory and their effect on our gross profits and results of operations if demand for our products declines or we maintain excess inventory levels; our ability to manage growth and spending during economic downturns; our manufacturing capacity and operations and their suitability for future levels of demand; our reliance on third parties to manufacture certain of our products and product components; our reliance on a small number of customers for a significant portion of our revenues; our ability to manage risks associated with international customers and operations; the effect of government export and import controls on our ability to compete in international markets; our ability to protect our proprietary technology and intellectual property rights; fluctuations in our quarterly results of operations and other operating measures; and the effect on our business of claims, lawsuits, government investigations, other legal or regulatory proceedings, or commercial or contractual disputes that we are or may become involved in. Additional information concerning these and other factors can be found in nLIGHT's filings with the Securities and Exchange Commission (the “SEC”), including other risks, relevant factors and uncertainties identified in the “Risk Factors” section of nLIGHT's most recent Annual Report on Form 10-K or subsequent filings with the SEC. nLIGHT undertakes no obligation to update publicly or revise any forward-looking statements contained herein to reflect future events or developments, except as required by law.

The nLIGHT logo and “nLIGHT” are registered trademarks or trademarks of nLIGHT, Inc. in various jurisdictions.

About nLIGHT nLIGHT, Inc. is a leading provider of high-power lasers for mission critical directed energy, optical sensing, and advanced manufacturing applications. Headquartered in Camas, Washington, nLIGHT employs more than 800 people with operations in the United States, Europe and Asia. The company’s vertically integrated approach enables performance leadership from laser chip through system-level solutions. For more information, please visit www.nlight.net.

For more information, contact:

John Marchetti

VP Corporate Development and Investor Relations nLIGHT, Inc.

(360) 566-4460 john.marchetti@nlight.net nLIGHT, Inc.

Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited) nLIGHT, Inc.

Condensed Consolidated Balance Sheets

(In thousands)

(Unaudited) nLIGHT, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited) nLIGHT, Inc.

Reconciliation of GAAP Financial Metrics to Non-GAAP

(In thousands, except per share data)

(Unaudited)

Reconciliation of GAAP to Non-GAAP Gross Profit

Reconciliation of Net Loss to Adjusted EBITDA

Reconciliation of GAAP to Non-GAAP Net Loss, and GAAP to Non-GAAP Net Loss per Share, Basic and Diluted

(1)

There is no income tax effect related to the stock-based compensation and amortization of purchased intangibles adjustments due to the full valuation allowance in the United States. nLIGHT, Inc.

Supplemental Schedule of Financial Information

(In thousands)

(Unaudited)

Revenues by End Market

## Financial statements

### Income Statement (Three Months Ended March 31, — First Quarter 2026 Financial Highlights (In thousands, except percentages))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 | % Change |
|---|---:|---:|---:|
| Revenues | 80,181 | 51,668 | 55.2% |
| Gross margin | 33.1% | 26.7% |  |
| Loss from operations | -719 | -9,610 | 92.5% |
| Operating margin | -0.9% | -18.6% |  |
| Net income (loss) | 645 | -8,093 | NM* |
| Adjusted EBITDA(1) | 13,831 | 116 | NM* |
| (1) A reconciliation of the non-GAAP metrics presented here to the most directly comparable GAAP metric has been provided in the tables included at the end of this release. | (1) A reconciliation of the non-GAAP metrics presented here to the most directly comparable GAAP metric has been provided in the tables included at the end of this release. | (1) A reconciliation of the non-GAAP metrics presented here to the most directly comparable GAAP metric has been provided in the tables included at the end of this release. |  |

### Income Statement (Three Months Ended March 31, — (Unaudited))

| | Three Months Ended March 31, – 2026 | 2025 |
|---|---:|---:|
| Revenue: | Products | 58,202 | 35,678 |
| Revenue: | Development | 21,979 | 15,990 |
| Revenue: | Total revenue | 80,181 | 51,668 |
| Cost of revenue: | Products | 32,810 | 23,724 |
| Cost of revenue: | Development | 20,858 | 14,145 |
| Cost of revenue: | Total cost of revenue(1) | 53,668 | 37,869 |
| Cost of revenue: | Gross profit | 26,513 | 13,799 |
| Operating expenses: | Research and development(1) | 11,846 | 11,374 |
| Operating expenses: | Sales, general, and administrative(1) | 15,091 | 12,035 |
| Operating expenses: | Restructuring | 295 |  |
| Operating expenses: | Total operating expenses | 27,232 | 23,409 |
| Operating expenses: | Loss from operations | -719 | -9,610 |
| Other income: | Interest income | 1,562 | 1,688 |
| Other income: | Interest (expense) | -300 | -48 |
| Other income: | Other income, net | 155 | 14 |
| Other income: | Income (loss) before income taxes | 698 | -7,956 |
| Other income: | Income tax expense | 53 | 137 |
| Other income: | Net income (loss) | 645 | -8,093 |
| Other income: | Net income (loss) per share, basic | 0.01 | -0.16 |
| Other income: | Net income (loss) per share, diluted | 0.01 | -0.16 |
| Shares used in per share calculations: | Basic | 54,121 | 49,093 |
| Shares used in per share calculations: | Diluted | 59,975 | 49,093 |

### Income Statement ((Unaudited))

| | Three Months Ended March 31, – 2026 | 2025 |
|---|---:|---:|
| (1)Includes stock-based compensation as follows: | Cost of revenues | 1,054 | 570 |
| (1)Includes stock-based compensation as follows: | Research and development | 2,261 | 1,784 |
| (1)Includes stock-based compensation as follows: | Sales, general, and administrative | 7,571 | 3,702 |
| (1)Includes stock-based compensation as follows: |  | 10,886 | 6,056 |

### Income Statement (Three Months Ended March 31, — Reconciliation of GAAP to Non-GAAP Gross Profit)

| | Three Months Ended March 31, – 2026 – Products | Three Months Ended March 31, – 2026 – Development | Three Months Ended March 31, – 2026 – Total | Three Months Ended March 31, – 2025 – Products | Three Months Ended March 31, – 2025 – Development | Three Months Ended March 31, – 2025 – Total |
|---|---:|---:|---:|---:|---:|---:|
| Revenue | 58,202 | 21,979 | 80,181 | 35,678 | 15,990 | 51,668 |
| Cost of revenue | -32,810 | -20,858 | -53,668 | -23,724 | -14,145 | -37,869 |
| Gross profit | 25,392 | 1,121 | 26,513 | 11,954 | 1,845 | 13,799 |
| Non-GAAP adjustments | Stock-based compensation | 590 | 464 | 1,054 | 570 |  | 570 |
| Non-GAAP adjustments | Non-GAAP gross profit | 25,982 | 1,585 | 27,567 | 12,524 | 1,845 | 14,369 |
| Non-GAAP adjustments | Gross margin | 43.6 | 5.1 | 33.1 | 33.5 | 11.5 | 26.7 |
| Non-GAAP adjustments | Non-GAAP gross margin | 44.6 | 7.2 | 34.4 | 35.1 | 11.5 | 27.8 |

### Income Statement (Three Months Ended March 31, — Reconciliation of Net Loss to Adjusted EBITDA)

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net income (loss) | 645 | -8,093 |
| Income tax expense | 53 | 137 |
| Other income, net | -155 | -14 |
| Interest income | -1,562 | -1,688 |
| Interest expense | 300 | 48 |
| Depreciation and amortization | 3,369 | 3,670 |
| Stock-based compensation | 10,886 | 6,056 |
| Restructuring charges | 295 |  |
| Adjusted EBITDA | 13,831 | 116 |

### Balance Sheet ((Unaudited))

| | As of – March 31, 2026 | As of – December 31, 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 298,211 | 98,699 |
| Current assets: | Marketable Securities | 34,383 | 34,934 |
| Current assets: | Accounts receivable, net | 48,105 | 50,836 |
| Current assets: | Inventory | 43,864 | 45,407 |
| Current assets: | Prepaid expenses and other current assets | 21,502 | 13,314 |
| Current assets: | Total current assets | 446,065 | 243,190 |
| Current assets: | Restricted cash | 322 | 322 |
| Current assets: | Lease right-of-use assets | 14,266 | 15,020 |
| Current assets: | Property, plant and equipment, net | 40,897 | 42,114 |
| Current assets: | Goodwill | 12,432 | 12,448 |
| Current assets: | Other assets, net | 1,717 | 2,116 |
| Current assets: | Total assets | 515,699 | 315,210 |
| Current liabilities: | Accounts payable | 19,125 | 20,890 |
| Current liabilities: | Accrued liabilities | 16,929 | 19,052 |
| Current liabilities: | Deferred revenue | 4,093 | 1,489 |
| Current liabilities: | Current portion of lease liabilities | 2,902 | 2,776 |
| Current liabilities: | Line of credit | 20,000 | 20,000 |
| Current liabilities: | Total current liabilities | 63,049 | 64,207 |
| Current liabilities: | Non-current income taxes payable | 5,991 | 5,902 |
| Current liabilities: | Long-term lease liabilities | 12,681 | 13,431 |
| Current liabilities: | Other long-term liabilities | 4,741 | 4,921 |
| Current liabilities: | Total liabilities | 86,462 | 88,461 |
| Stockholders' equity: | Common stock - par value | 17 | 16 |
| Stockholders' equity: | Additional paid-in capital | 780,482 | 578,360 |
| Stockholders' equity: | Accumulated other comprehensive loss | -3,344 | -3,064 |
| Stockholders' equity: | Accumulated deficit | -347,918 | -348,563 |
| Stockholders' equity: | Total stockholders’ equity | 429,237 | 226,749 |

### Cash Flow (Three Months Ended March 31, — (Unaudited))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Cash flows from operating activities: | Net loss | 645 | -8,093 |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | Depreciation | 3,158 | 3,172 |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | Amortization | 211 | 498 |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | (Increase) reduction in carrying amount of right-of-use assets | 723 | -473 |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | Provision for losses on (recoveries of) accounts receivable | -9 | -466 |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | Stock-based compensation | 10,886 | 6,056 |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | Deferred income taxes | -3 | -3 |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | Loss on disposal of property, plant and equipment | 24 | 62 |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | Interest earned on marketable securities not yet received | -231 | -227 |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | Non-cash restructuring charges | 295 |  |
| Changes in operating assets and liabilities: | Accounts receivable, net | 2,736 | -768 |
| Changes in operating assets and liabilities: | Inventory | 1,343 | -2,811 |
| Changes in operating assets and liabilities: | Prepaid expenses and other current assets | -8,165 | -959 |
| Changes in operating assets and liabilities: | Other assets, net | 189 | 502 |
| Changes in operating assets and liabilities: | Accounts payable | -1,637 | 2,018 |
| Changes in operating assets and liabilities: | Accrued and other long-term liabilities | -2,528 | 1,693 |
| Changes in operating assets and liabilities: | Deferred revenues | 2,610 | -736 |
| Changes in operating assets and liabilities: | Lease liabilities | -594 | 450 |
| Changes in operating assets and liabilities: | Non-current income taxes payable | 30 | 65 |
| Changes in operating assets and liabilities: | Net cash provided by (used in) operating activities | 9,683 | -20 |
| Cash flows from investing activities: | Purchases of property, plant and equipment | -2,113 | -2,281 |
| Cash flows from investing activities: | Purchase of marketable securities | -34,173 | -34,288 |
| Cash flows from investing activities: | Proceeds from maturities and sales of marketable securities | 34,918 | 34,136 |
| Cash flows from investing activities: | Net cash used in investing activities | -1,368 | -2,433 |
| Cash flows from financing activities: | Proceeds from public offerings, net of offering costs | 191,275 |  |
| Cash flows from financing activities: | Proceeds from line of credit |  | 20,000 |
| Cash flows from financing activities: | Proceeds from stock option exercises | 150 | 121 |
| Cash flows from financing activities: | Tax payments related to stock award issuances | -190 | -1,356 |
| Cash flows from financing activities: | Net cash provided by financing activities | 191,235 | 18,765 |
| Cash flows from financing activities: | Effect of exchange rate changes on cash | -38 | 56 |
| Cash flows from financing activities: | Net increase in cash, cash equivalents and restricted cash | 199,512 | 16,368 |
| Cash flows from financing activities: | Cash, cash equivalents and restricted cash, beginning of period | 99,021 | 66,088 |
| Cash flows from financing activities: | Cash, cash equivalents and restricted cash, end of period | 298,533 | 82,456 |
| Supplemental disclosures: | Cash paid for interest, net | 288 | 12 |
| Supplemental disclosures: | Operating cash outflows from operating leases | 797 | 855 |
| Supplemental disclosures: | Right-of-use assets obtained in exchange for lease liabilities | -32 | 1,188 |
| Supplemental disclosures: | Accrued purchases of property, equipment and patents | 222 | 337 |
| Reconciliation of cash and cash equivalents and restricted cash: | Cash and cash equivalents | 298,211 | 82,196 |
| Reconciliation of cash and cash equivalents and restricted cash: | Restricted cash | 322 | 260 |
| Reconciliation of cash and cash equivalents and restricted cash: | Total cash and cash equivalents and restricted cash | 298,533 | 82,456 |
